DMTC has released its 2021 Annual Report, showcasing the work of the company and its partners in advancing technologies identified as priorities by defence and national security agencies.
The Report includes forewords from the Minister for Defence Industry and sector leaders, feature stories, performance information and program highlights.
We asked industry leaders and technical experts, including Medicines Australia and Pfizer Australia, to join us to discuss the importance of the National Health Security Resilience Assessment, and the opportunity for Australia’s industrial and research sectors to ensure their contributions count.
Speakers included:
Dr Leigh Farrell, Head Health Security Systems Australia
Ms Elizabeth de Somer, Chief Executive Medicines Australia
Ms Anne Harris, Managing Director Pfizer Australia & New Zealand
A collaboration between Melbourne chemical company Boron Molecular and DMTC Limited is testing a new system capable of synthesising drugs at scale, quickly and continuously. (more…)
DMTC Limited has released the digital version of its 2020 Annual Report, showcasing achievements across a broad portfolio of defence-relevant industrial innovation and technology development projects.